Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide

Journal of Cosmetic Dermatology

Volumn 8, Issue 4, 2009, Pages 260-266

  Bissett, Donald L ^a   Robinson, Larry R ^a   Raleigh, Patricia S ^a   Miyamoto, Kukizo ^a   Hakozaki, Tomohiro ^a   Li, Jim ^a   Kelm, Gary R ^a   Johnson, Mary ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Anti aging; Clinical; Niacinamide; Nundecylenoyl phenylalanine; Phenylalanine derivative; Pigmentation

Indexed keywords

ALPHA INTERMEDIN DERIVATIVE; N UNDECYL 10 ENOYL PHENYLALANINE; NICOTINAMIDE; PLACEBO; SEPIWHITE; UNCLASSIFIED DRUG;

ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; EMULSION; FACE; FEMALE; HUMAN; HYPERPIGMENTATION; IMAGE ANALYSIS; JAPANESE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN PENETRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FACIAL DERMATOSES; FEMALE; HUMANS; HYPERPIGMENTATION; MIDDLE AGED; NIACINAMIDE; PHENYLALANINE;

EID: 76849087863     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00470.x     Document Type: Article

References (15)

1. Zhu W-Y, Zhang R-Z. Skin lightening agents. In: ZD Draelos, LA Thaman, eds. Cosmetic Science and Technology Series, Volume 30, Cosmetic Formulation of Skin Care Products. New York: Taylor & Francis; 2006: pp. 205-17.
2. Ortonne J-P, Bose SK. Pigmentation: dyschromia. In: R Baran, HI Maibach, eds. Textbook of Cosmetic Dermatology. New York: Taylor & Francis; 2005: pp. 393-409.
3. Joseph CG, Wilczynski A, Holder JR, Xiang Z, Bauzo RM, Scott JW, Haskell-Luevano C. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity. Peptides 2003; 24: 1899-1908.
4. Holder JR, Bauzo RM, Xiang Z, Haskell-Luevano C. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors: part 2 modifications at the Phe position. J Med Chem 2002; 45: 3073-81.
5. Haskell-Luevano C, Cone RD, Monck EK, Wan Y-P. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: Identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 2001; 40: 6164-79.
6. Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 20-31.
7. Greatens A, Hakozaki T, Koshoffer A, Epstein H, Schwemberger S, Babcock G, Bissett D, Takiwaki H, Arase S, Wickett RR, Boissy RE. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol 2005; 14: 498-508.
8. Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci 2004; 26: 231-8.
9. Miyamoto K, Takiwaki H, Hillebrand GG, Arase S. Development of a digital imaging system for objective measurement of hyperpigmented spots on the face. Skin Res Technol 2002; 8: 227-35.
10. National Weather Service. Climate Prediction Center. WV Index: Annual Time Series. Indianapolis, IN: Daily UV Index; 2005. Available at http://www.cpc.ncep.noaa.gov/ products/stratosphere/uv_index/gif_files/ind_05.png, accessed 30 April 2008.
11. Bissett DL, Robinson LR, Raleigh PS, Miyamoto K, Hakozaki T, Li J, Kelm GR. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 2007; 6: 20-6.
12. Schallreuter KU, Wood JM, Pittelkow MR, Gütlich M, Lemke KR, Rödl W, Swanson NN, Hitzemann K, Ziegler I. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994; 263: 1444-6.
13. Schallreuter KU, Moore J, Tobin DJ, Gibbons NJ, Marshall HS, Jenner T, Beazley WD, Wood JM. Alpha-MSH can control the essential cofactor 6-tetrahydrobiopterin in melanogenesis. Ann NY Acad Sci 1999; 885: 329-41.
14. Schallreuter KU. A review of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol 1999; 45: 943-9.
15. Tokiwa Y, Kitagawa M, Raku T, Yanagitani S, Yoshino K. Enzymatic synthesis of arbutin undecylenic acid ester and its inhibitory effect on melanin synthesis. Bioorg Med Chem Lett 2007; 17: 3105-8.